NASDAQ:DRMA | Cash Flow Statement | Dermata Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.97M
2026-03-31-$1.85M-$2.48M$1.9M
2025-12-31-$1.86M-$1.33M$4.19M
2025-09-30-$1.69M
2025-06-30-$1.7M
2025-03-31-$2.3M-$1.93M$8.49M
2024-12-31-$3.15M-$2.91M-$68,568.00
2024-09-30-$3.17M
2024-06-30-$2.83M
2024-03-31-$3.13M-$2.7M$0.00
2023-12-31-$2.13M-$1.15M$1.95M
2023-09-30-$1.72M
2023-06-30-$1.7M
2023-03-31-$2.24M-$1.65M$4.18M
2022-12-31-$1.67M-$1.83M$0.00
2022-09-30-$2.42M
2022-06-30-$2.73M
2022-03-31-$2.79M-$2.61M$0.00
2021-12-31-$2.55M-$1.8M-$626.00
2021-09-30-$1.71M
2021-06-30-$1.33M
2021-03-31-$2.3M-$776,220.00$1.58M
2020-12-31-$396,313.00-$7.52M$313,328.00
2020-09-30-$597,395.00
2020-06-30-$821,649.00
2020-03-31-$1.42M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$7.56M-$7.76M$12.12M
2024-12-31-$12.29M-$11.16M$6.89M
2023-12-31-$7.79M-$6.41M$7.61M
2022-12-31-$9.61M-$8.83M$4.28M
2021-12-31-$7.9M-$5.69M$15.96M
2020-12-31-$3.24M-$4.03M$2.57M